CAH Stock UPDATES Cardinal Health (CAH) 70.94 08/10/2014 19:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cardinal Health (CAH) 70.94 $CAH

Cardinal Health Board of Directors Approves Quarterly Dividend, Authorizes Increase to Share Repurchase Program, Announces Board Leadership Changes
PR Newswire - Wed Aug 06, 3:05PM CDT
Cardinal Health today announced that its board of directors approved a cash dividend of $0.3425 per common share payable on Oct. 15, 2014, to shareholders of record at the close of business on Oct. 1, 2014.

Earnings Results and Awards - Research Reports on Spirit, Armstrong, Ingersoll-Rand, ITW and Cardinal Health
PR Newswire - Wed Aug 06, 8:00AM CDT
Today, Analysts Review released its research reports regarding Spirit AeroSystems Holdings, Inc. (NYSE: SPR), Armstrong World Industries, Inc. (NYSE: AWI), Ingersoll-Rand Plc (NYSE: IR), Illinois Tool Works Inc. (NYSE: ITW) and Cardinal Health, Inc. (NYSE: CAH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5496-100free.

NYSE stocks posting largest percentage decreases
AP - Tue Aug 05, 12:21PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at 1 p.m.:

Will This Price Target Increase Help Cardinal Health (CAH) Stock Today?
at The Street - Tue Aug 05, 8:12AM CDT
Credit Suisse increased its price target on Cardinal Health (CAH) to $80 from $76 and set an "outperform" rating.

India Patient Monitoring and Diagnostic Systems Market Growth Trends, 2006 - 2019
M2 - Tue Aug 05, 5:37AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n5h8m7/india_patient) has announced the addition of the "India Patient Monitoring and Diagnostic Systems Market Growth Trends, 2006 - 2019" report to their offering. The Market Intelligence report provides critical market data for India Patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Scope of the Report 4 Indian Market for Patient Monitoring and Diagnostics (2006-2019) 5 Indian Market for Blood Pressure Monitors (2006-2019) 6 Indian Market for Cardiovascular Monitoring Systems (2006-2019) 7 Indian Market for Blood Glucose Monitoring Devices (2006-2019) 8 Indian Market for Hearing Diagnostics (2006-2019) 9 Indian Market for Micro-Electromechanical Systems(2006-2019) 10 Indian Market for Multiparameter Patient Monitors (2006-2019) 11 Indian Market for Remote Monitoring Systems (2006-2019) 12 Indian Market for Sleep Apnea Diagnostic Systems (2006-2019) 13 Indian Market for Wireless Hospital Ambulatory Monitors (2006-2019) 14 Recent Events and Developments 15 Appendix Companies Mentioned: - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - Natus Medical Incorporated - Nihon Kohden Corporation - OMRON HEALTHCARE Co., Ltd. - OSI Systems, Inc. - Philips Medical Systems - Schiller AG - St. Jude Medical Inc. - Terumo Corporation - Welch Allyn Inc. - William Demant Holding A/S For more information visit http://www.researchandmarkets.com/research/n5...ia_patient

India Sleep Apnea Diagnostic Systems Market, 2006 - 2019
M2 - Tue Aug 05, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/whn3h9/india_sleep_apnea) has announced the addition of the "India Sleep Apnea Diagnostic Systems Market, 2006 - 2019" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the sleep apnea diagnostic systems in India through 2019. The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2006 to 2019. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. - Market share of companies. - Average selling price ($) for each product type (2006 to 2019). - Recent Events and Developments Why should you buy? - Build business strategy by identifying the high growth and attractive market categories. - Develop competitive strategy based on competitive landscape. - Design capital investment strategies based on forecasted high potential segments. - Identify potential business partners, acquisition targets and business buyers. - Plan for a new product launch and inventory in advance. - Prepare management and strategic presentations using the market data. - To review unbiased and independent assessment of the market data. Key Topics Covered: 1 Table of Contents 2. Introduction 3. Scope of the Report 4. Indian Market for Sleep Apnea Diagnostic Systems, 2006-2019 5. Recent Events and Developments 6. Appendix Companies Mentioned: - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - Astro-Med, Inc. - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Embla Systems - ResMed Inc. - Natus Medical Incorporated - Nihon Kohden Corporation - Philips Medical Systems For more information visit http://www.researchandmarkets.com/research/wh...leep_apnea

Jim Cramer's Top Stock Picks: ACT AMZN CAH AAPL
at The Street - Tue Aug 05, 5:00AM CDT
Cramer says Actavis is inexpensive and has room to grow while Amazon can begin to rebound soon.

Canada Respiratory Devices Report, 2006 - 2019
M2 - Tue Aug 05, 4:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qvgj97/canada) has announced the addition of the "Canada Respiratory Devices Report, 2006 - 2019" report to their offering. The Market Intelligence report provides critical market data for Canada respiratory devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as positive airway pressure devices, humidifiers, oxygen concentrator, ventilators, respiratory disposables, and respiratory measurement devices. Market Size - Market size in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2019. Market Growth - Market growth in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2019. Competitive Analysis - Market share (%) of companies is covered at sector and category level for 2013. Pricing Analysis - Average selling price ($) for each product type from 2006 - 2013 and forecast till 2019. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Scope of the Report 4 Canadian Market for Respiratory Devices (2006-2019) 5 Argentinean Market for Positive Airway Pressure Devices (2006-2019) 6 Argentinean Market for Humidifiers (2006-2019) 7 Argentinean Market for Oxygen Concentrators (2006-2019) 8 Argentinean Market for Ventilators (2006-2019) 9 Argentinean Market for Nrbulizers (2006-2019) 10 Argentinean Market for Respiratory Disposables (2006-2019) 11 Argentinean Market for Respiratory Measurement Devices (2006-2019) 12 Recent Events and Developments 13 Appendix Companies Mentioned: - Cardinal Health, Inc. - Covidien Ltd. - Drager Medical AG & Co. KG - GE Healthcare - MAQUET GmbH & Co. KG - Philips Medical Systems - ResMed Inc. - Smiths Medical - Sunrise Medical For more information visit http://www.researchandmarkets.com/research/qvgj97/canada

Jim Cramer's 'Mad Money' Recap: Watch Your Back
at The Street - Mon Aug 04, 6:59PM CDT
Forget what the pundits say, the real reason for the market's turmoil remains Russia, Cramer says.

Cardinal down on guidance
at Investor's Business Daily - Mon Aug 04, 5:57PM CDT
The pharmaceutical distributor reported lower quarterly revenue for the 8th quarter in a row, after a contract with Walgreen (WAG) expired last year. Cardinal Health (CAH) gave profit guidance for the coming year that largely missed analyst...

4 Big Stocks on Traders' Radars
at The Street - Mon Aug 04, 1:43PM CDT
Here's how to trade some of the most active stocks on the market today.

Cardinal Health's Fiscal Q4 Earnings Rise and Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 11:25AM CDT
For fiscal 2015, Cardinal Health (CAH) predicted adjusted earnings per share in the band of $4.10 to $4.30, reflecting an estimated rise of 6.8 to 12.0% over fiscal 2013

Why Cardinal Health (CAH) Stock Is Down Today
at The Street - Mon Aug 04, 10:33AM CDT
Shares of Cardinal Health (CAH) are down after the company said its fiscal fourth quarter revenue declined, due to the continuing impact of the expiration of the Walgreen (WAG) contract.

Cardinal Health Guides Low As Revenue Keeps Sliding
at Investor's Business Daily - Mon Aug 04, 10:28AM CDT
Cardinal Health (CAH) reported lower quarterly revenue for an eighth quarter in a row and offered profit guidance for the coming year that largely missed analyst estimates. The drug distributor expects earnings per share for fiscal 2015 of...

Unusual Social Activity Around Cardinal Health (CAH) Today
at The Street - Mon Aug 04, 10:08AM CDT
Trade-Ideas LLC identified Cardinal Health (CAH) as an unusual social activity candidate

Cardinal Health Reports Fourth-Quarter And Fiscal Year Results, Provides Fiscal 2015 Outlook
PR Newswire - Mon Aug 04, 6:00AM CDT
Cardinal Health today reported earnings for its fiscal 2014 fourth quarter and year-end.

Is Cardinal Health (CAH) Poised to Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 01, 4:55PM CDT
Our proven model shows that Cardinal Health (CAH) is likely to beat earnings.

Watch for Cardinal Health to Potentially Pullback After Gaining 1.05% Yesterday
Comtex SmarTrend(R) - Fri Aug 01, 4:11PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $71.57 to a high of $73.14. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $72.84 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 328

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 214

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Fabhalta® Breakthrough in PNH Treatment Showcased

Updated Category News Views 290

Novartis Fabhalta® Achieves Significant Hemoglobin Improvements In recent studies, Novartis has showcased promising results from its Phase IIIB APPULSE-PNH study regarding Fabhalta (iptacopan), designed for adult patients suffering from paroxysmal nocturnal hemoglobinuria (PNH). Patients who switched from anti-C5 therapies demonstrated noteworthy improvement in their...

Continue Reading
Insights into Indonesia's Economic Landscape for Credit Investors

Updated Category News Views 208

Understanding Indonesia's Market Dynamics This week, Gimme Credit unveiled a new Indonesia Country Report that delves into the recent fluctuations in the equity market and its potential ripple effects on foreign exchange and bond markets. The inquiry raises fundamental questions about whether these shifts could necessitate a higher risk premium for those investing in...

Continue Reading
Pliant Therapeutics to Showcase Innovations at Key Healthcare Conference

Updated Category News Views 187

Introduction to Pliant Therapeutics' Participation Pliant Therapeutics, Inc. (NASDAQ: PLRX), a dedicated force in the clinical-stage biotechnology sector, is set to make waves at an upcoming healthcare conference. The event serves as a platform for the company to showcase its integrin-based therapeutics—game-changing innovations aimed at treating various serious health...

Continue Reading
OSB Group PLC Financial Performance Overview for 2025

Updated Category News Views 322

OSB Group PLC Trading Update Summary OSB GROUP PLC, a specialist lending and retail savings group, is pleased to share its trading update for the nine-month period concluding on 30 September 2025. This report highlights the Group's steady growth and enhanced financial performance in line with expectations and strategic objectives. Performance Insights for the Nine-Month...

Continue Reading
Toll Brothers Unveils Luxurious Homes at Ridge Pointe Estates

Updated Category News Views 222

Toll Brothers Unveils New Luxury Homes at Ridge Pointe Estates Toll Brothers, Inc. (NYSE: TOL), recognized as a leader in the luxury home construction industry, has introduced its latest community, Ridge Pointe Estates. This community, now officially open, offers prospective homeowners a blend of elegance and modern living. Located within a serene setting, Ridge Pointe...

Continue Reading